Persistence of inclusion conjunctivitis after oral erythromycin therapy.
Laperrière
H
H
Centre local de services communautaires Saint-Louis du Parc, Montreal.
Lefebvre
J
J
D000284:Administration, Oral; D002690:Chlamydia Infections; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D003235:Conjunctivitis, Inclusion / Q000188:drug therapy* / Q000209:etiology; D004917:Erythromycin / Q000031:analogs & derivatives*; D004918:Erythromycin Estolate / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D012008:Recurrence
D004917:Erythromycin; D004918:Erythromycin Estolate